Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001546927-15-000162
Filing Date
2015-05-20
Accepted
2015-05-20 11:59:59
Documents
1
Period of Report
2015-05-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT opaleyeimmyform4filed.html 4  
1 OWNERSHIP DOCUMENT opaleyeimmyform4filed.xml 4 4424
  Complete submission text file 0001546927-15-000162.txt   6200
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9B RUSSELL STREET CAMBRIDGE MA 02140
Business Address 9B RUSSELL STREET CAMBRIDGE MA 02140 617-997-9567
Opaleye Management Inc. (Reporting) CIK: 0001595855 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 15878739